Vallige

Science Simplified

Science Simplified: Ninety Percent

Team Vallige
3 min read
Science Simplified icon

Ninety percent.

In a major study published in JAMA, that's how often a simple blood test correctly identified Alzheimer's disease. Dementia specialists got it right 73 percent of the time. Primary care doctors got it right 61 percent of the time.

So doctors who spend their careers on this diagnosis were right about three times out of four. A blood draw was right nine times out of ten.

This wasn't a small pilot. Researchers led by Sebastian Palmqvist followed 1,213 patients with cognitive symptoms through primary and specialty care clinics across Sweden from 2020 to 2024.

Each patient's blood was tested for a biomarker called p-tau217. Those results were checked against the gold standard: brain imaging and spinal fluid tests that confirm, with near certainty, whether Alzheimer's pathology is present. Separately, physicians made their diagnosis the usual way, using symptoms, history, memory testing and their own judgment.

The blood test won, and not by a little.

The study was done in one country, and these tests aren't routine at every clinic yet, although the FDA has now cleared several p-tau217 blood tests in the US. Still, the result held whether patients saw a specialist or a general practitioner. The GP's office is where diagnosis most often goes sideways.

Why a blood test can see what an exam can't

Alzheimer's involves two proteins, amyloid and tau, building up in the brain. That buildup often starts a decade or more before symptoms are noticeable enough to bring someone to a doctor. As tau tangles form, small pieces of tau, including p-tau217, leak into the bloodstream in tiny amounts that can be measured.

A blood test reads that biology directly. A doctor's exam reads symptoms.

And symptoms are misleading. Memory lapses, confusion and personality changes also show up with depression, medication side effects, thyroid problems and normal aging. Even a skilled specialist is working from a checklist that can't see inside the brain.

That's the gap behind those three numbers.

What the gap looks like at home

For many families, that gap is very real. It's a year of appointments. It's hearing "let's wait and see" more times than you can count. It's a parent who clearly isn't themselves, and a room full of professionals who can't agree on why.

World Alzheimer's Day was September 21, and this year's World Alzheimer's Month theme from Alzheimer's Disease International puts it plainly: the earlier you know, the more you can do. A diagnosis you can trust, and get sooner, is more than a medical milestone. It opens the door to treatment options and care planning, and it lets families stop wondering and start acting.

Where Vallige fits, and where we don't

To be clear: Vallige doesn't diagnose anything, and we don't offer this blood test. That work belongs to physicians.

We're here for what comes after. Once a family has clarity, whatever the diagnosis, the question becomes what to do with the time it gives them. That's where the Daily Digest and Talkstories come in. They don't tell you what's happening in someone's brain. They help a family stay connected to who that person is, together, as a Village.

If you're in the uncertain part right now, sitting through appointments, hearing "let's monitor it," living with not knowing, this is for you. That stage is exhausting in a way that's hard to explain to anyone who hasn't been through it.

Science like this is closing the gap between not knowing and knowing. Whatever the answer turns out to be, you don't have to face it alone.

Sources

Related Posts